Khoso Baluch, Chief Executive Officer at CorMedix Inc. (CRMD), bought 3,500 shares at $2.61 ($9K) on 2020-03-18, disclosed to the SEC on 2020-03-18.
Open-market purchase of $9k CRMD by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| LGVN | BUY | 2024-01-02 | $14K | — | Filing → |
| CRMD | BUY | 2020-08-17 | $20K | — | Filing → |
| CRMD | BUY | 2019-03-27 | $19K | — | Filing → |